BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2021 5:46:25 AM | Browse: 371 | Download: 1207
 |
Received |
|
2021-02-08 08:08 |
|
Peer-Review Started |
|
2021-02-08 08:11 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-08 05:18 |
|
Revised |
|
2021-03-10 03:30 |
|
Second Decision |
|
2021-04-16 12:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-21 03:18 |
|
Articles in Press |
|
2021-04-21 03:18 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-30 10:00 |
|
Typeset the Manuscript |
|
2021-08-19 03:08 |
|
Publish the Manuscript Online |
|
2021-08-20 05:46 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Minireviews |
| Article Title |
Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 infected pulmonary diseases: From bench to bedside
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Lei-Sheng Zhang, Yi Yu, Hao Yu and Zhong-Chao Han |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shandong Provincial Natural Science Foundation |
ZR2020QC097 |
| China Postdoctoral Science Foundation |
2019M661033 |
| Jiangxi key new product incubation program funded by Technical Innovation Guidance Program of Shangrao city |
2020G002 |
| Tianjin Science and Technology Project for Overseas Student |
JH-20180070802 |
| Natural Science Foundation of Tianjin |
19JCQNJC12500 |
| Major Project of Fundamental Research Funds of the Central Public Welfare Scientific Research Institutes of the Chinese Academy of Medical Sciences |
2018PT31048 |
| Major Project of Fundamental Research Funds of the Central Public Welfare Scientific Research Institutes of the Chinese Academy of Medical Sciences |
2019PT310013 |
| National Science and Technology Major Projects of China for "Major New Drugs Innovation and Development" |
2014ZX09508002-003 |
| National Natural Science Foundation of China |
81330015 |
| Science and Technology Project of Tianjin |
17ZXSCSY00030 |
|
| Corresponding Author |
Hao Yu, PhD, Associate Professor, Postdoctoral Fellow, School of Medicine, Nankai University, No. 94 Weijin Road, Nankai District, Tianjin 300071, China. yuhao-wuhan@hotmail.com |
| Key Words |
Mesenchymal stem/stromal cells; COVID-19; Acute lung injury; Acute respiratory distress syndrome; Pulmonary fibrosis; Molecular mechanism |
| Core Tip |
Coronavirus disease 2019 (COVID-19) is a global pandemic and seriously threatens people’s lives. Due to the limitation of current traditional remedies as well as the rapid disease progression, inpatients with severe pulmonary manifestations and accompanied comorbidities are inclined to worse outcomes. Herein, we review the latest updates of the mesenchymal stem/stromal cells-based cytotherapy for COVID-19 management, together with discuss the principles and underlying molecular mechanisms as well, which will collectively benefit the novel comprehensive treatment for COVID-19 infected cases. |
| Publish Date |
2021-08-20 05:46 |
| Citation |
Zhang LS, Yu Y, Yu H, Han ZC. Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 infected pulmonary diseases: From bench to bedside. World J Stem Cells 2021; 13(8): 1058-1071 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i8/1058.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i8.1058 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
